Tandem Diabetes Care (TNDM) Cash from Operations (2013 - 2026)

Tandem Diabetes Care's Cash from Operations history runs 14 years deep, the most recent figure standing at 11054000.0 for Q1 2026.

• Quarterly Cash from Operations rose 160.48% year-over-year to 11054000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19611000.0 (up 40.65% YoY) and the FY2025 annual result came in at 9721000.0, down 140.13% from the prior year.
• Cash from Operations was 11054000.0 for Q1 2026 at Tandem Diabetes Care, up from 9789000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 26779000.0 in Q3 2024 and bottomed at 18326000.0 in Q1 2023.
• A 5-year average of 2600705.88 and a median of 5820000.0 in 2022 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2023 — Cash from Operations plunged 232.8% — and 2024, when it surged 48589.09%.
• Tandem Diabetes Care's Cash from Operations stood at 5820000.0 in 2022, then tumbled by 223.99% to 7216000.0 in 2023, then jumped by 248.52% to 10717000.0 in 2024, then fell by 8.66% to 9789000.0 in 2025, then increased by 12.92% to 11054000.0 in 2026.
• Business Quant data shows TNDM's Cash from Operations at 11054000.0 in Q1 2026, 9789000.0 in Q4 2025, and 8264000.0 in Q3 2025.